Deutsche Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-609,809
| Closed | -$2.07M | – | 5099 |
|
2018
Q3 | $2.07M | Buy |
609,809
+324,464
| +114% | +$1.1M | ﹤0.01% | 2815 |
|
2018
Q2 | $1.07M | Sell |
285,345
-19,377
| -6% | -$72.9K | ﹤0.01% | 3344 |
|
2018
Q1 | $1.25M | Buy |
304,722
+98,789
| +48% | +$404K | ﹤0.01% | 3149 |
|
2017
Q4 | $956K | Buy |
205,933
+104,585
| +103% | +$486K | ﹤0.01% | 3171 |
|
2017
Q3 | $718K | Buy |
101,348
+2,972
| +3% | +$21.1K | ﹤0.01% | 3163 |
|
2017
Q2 | $710K | Buy |
98,376
+75,032
| +321% | +$542K | ﹤0.01% | 3184 |
|
2017
Q1 | $142K | Sell |
23,344
-37,161
| -61% | -$226K | ﹤0.01% | 3591 |
|
2016
Q4 | $353K | Sell |
60,505
-104,357
| -63% | -$609K | ﹤0.01% | 3279 |
|
2016
Q3 | $873K | Buy |
164,862
+10,167
| +7% | +$53.8K | ﹤0.01% | 2849 |
|
2016
Q2 | $1.02M | Buy |
154,695
+133,316
| +624% | +$881K | ﹤0.01% | 2836 |
|
2016
Q1 | $98K | Sell |
21,379
-26,594
| -55% | -$122K | ﹤0.01% | 3853 |
|
2015
Q4 | $240K | Sell |
47,973
-294,829
| -86% | -$1.47M | ﹤0.01% | 3505 |
|
2015
Q3 | $1.21M | Buy |
342,802
+169,299
| +98% | +$595K | ﹤0.01% | 2786 |
|
2015
Q2 | $1.73M | Buy |
173,503
+105,068
| +154% | +$1.05M | ﹤0.01% | 2554 |
|
2015
Q1 | $868K | Sell |
68,435
-152,952
| -69% | -$1.94M | ﹤0.01% | 2905 |
|
2014
Q4 | $3.13M | Sell |
221,387
-22,839
| -9% | -$323K | ﹤0.01% | 2305 |
|
2014
Q3 | $3.35M | Buy |
244,226
+184,631
| +310% | +$2.54M | ﹤0.01% | 2098 |
|
2014
Q2 | $914K | Sell |
59,595
-14,270
| -19% | -$219K | ﹤0.01% | 2954 |
|
2014
Q1 | $1.26M | Sell |
73,865
-13,472
| -15% | -$229K | ﹤0.01% | 2708 |
|
2013
Q4 | $1.13M | Sell |
87,337
-822,858
| -90% | -$10.6M | ﹤0.01% | 2590 |
|
2013
Q3 | $9.18M | Buy |
910,195
+820,648
| +916% | +$8.28M | 0.01% | 1385 |
|
2013
Q2 | $667K | Buy |
+89,547
| New | +$667K | ﹤0.01% | 2979 |
|